APLM vs APM

Apollomics Inc. vs Aptorum Group Limited — Valuation Comparison 2026

APLM

Biotechnology
Apollomics Inc.
Quality
1.8
out of 10
Value Trap
Price
$14.06
Last close
Models
8/13
Active
VS

APM

Biotechnology
Aptorum Group Limited
Quality
2.2
out of 10
Value Trap
Price
$0.84
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType APLM Fair ValueAPLM Upside APM Fair ValueAPM Upside
Bayesian DCF Intrinsic $3.72 -73.5% $0.22 -73.6%
Earnings Power Value Intrinsic $0.06 -92.8%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $12.28 -11.9% $1.44 +69.6%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for APLM vs APM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

APLM vs APM — Which Stock Is More Undervalued?

APM scores higher with a 2.2/10 quality rating vs APLM's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Apollomics Inc. (APLM) and Aptorum Group Limited (APM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

APLM currently trades at $14.06 with a QOC of 1.8/10, while APM trades at $0.84 with a QOC of 2.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).